Nuance sees Q4 adjusted EPS 13c-18c, consensus 20c » 17:4808/0508/05/20
Sees Q4 revenue…
Nuance narrows FY20 EPS view to 78c-83c from 76c-86c, consensus 80c » 17:0808/0508/05/20
Narrows FY20 revenue view…
Nuance reports Q3 non-GAAP EPS 18c, consensus 12c » 16:0308/0508/05/20
Reports Q3 revenue…
Nuance expands AI collaboration with Cerner » 07:1807/3007/30/20
Nuance Communications …
Nuance Communications (NUAN) announced that it has expanded its long-standing AI collaboration with Cerner (CERN) to include the integration of Nuance's virtual assistant technology into the Cerner Millennium electronic health record. Building upon the existing integration between Nuance's Dragon Medical platform and Cerner Millennium, joint clients can utilize Nuance's advanced natural language virtual assistant technology to navigate the EHR using just their voice, giving clinicians more time to spend with their patients and less time with their computer. Select joint Cerner and Nuance clients can expect to start deploying this integrated virtual assistant technology later this year.
|Over a week ago|
Nuance price target raised to $30 from $20 at Morgan Stanley » 08:0007/1607/16/20
Morgan Stanley analyst…
Morgan Stanley analyst Sanjit Singh raised the firm's price target on Nuance to $30 from $20 and keeps an Overweight rating on the shares. Recent interviews with hospital CIOs and physicians substantiate the efficiency gains enabled by the company's Dragon Ambient Experience, or DAX, and leave Singh more optimistic that adoption will accelerate once the pandemic crisis subsides, the analyst tells investors. While continuing to assume no DAX contribution in FY20, Singh revised base case now formally includes DAX starts contributing to revenue in FY21, the analyst noted.
|Over a month ago|
SVB Leerink bullish on Nuance, initiates with an Outperform » 08:3106/2906/29/20
As previously reported,…
As previously reported, SVB Leerink analyst Stephanie Davis initiated coverage of Nuance with an Outperform rating and $31 price target. With consumer virtual assistant/AI solutions reaching mainstream status, the analyst believes Nuance is well positioned to ride this wave and introduce conversational AI technology in a more meaningful way to its end markets, fueling a multi-year growth and margin expansion story.
Nuance initiated with an Outperform at SVB Leerink » 06:1806/2906/29/20
SVB Leerink analyst…
SVB Leerink analyst Stephanie Davis initiated coverage of Nuance with an Outperform rating and $31 price target.
Nuance sees Q3 adjusted EPS 10c-14c, consensus 18c » 17:3505/0705/07/20
Sees Q3 revenue…
Sees Q3 revenue $302M-$328M, consensus $353.15M. Guidance taken from Q2 earnings conference call.
Nuance lowers FY20 non-GAAP EPS view to 76c-86c from 82c-90c, consensus 92c » 16:3205/0705/07/20
Lowers FY20 revenue view…
Lowers FY20 revenue view to $1.41B-$1.49B from $1.5B-$1.54B, consensus $1.48B.
Nuance reports Q2 non-GAAP EPS (21c), consensus (17c) » 16:2505/0705/07/20
Reports Q2 revenue…
Reports Q2 revenue $369.3M, consensus $352.99M. "Despite COVID-19, we had another excellent quarter, with revenue and EPS exceeding the high end of our guidance," said CEO Mark Benjamin. "We achieved 11% year-over-year organic revenue growth, with strength from both our Healthcare and Enterprise segments. Enterprise reported 19% annual revenue growth, the highest in 10 years, driven by our Intelligent Engagement solutions. Healthcare revenue grew 10% year-over-year, driven by strong growth in Dragon Medical cloud and increased demand from our newer cloud-based solutions, PowerScribe One and CDE One".